Verastem Oncology
VSTM
$9.38
Share price
1.79%
Change (1 day)
2,305.13%
Change (1 year)
Categories
Operating Margin for Verastem Oncology (VSTM)
Operating Margin as of April 2024 (TTM): -2,007.43%
According to Verastem Oncology 's latest financial reports and stock price the company's current Operating Margin is -2,007.43%. At the end of 2021 the company had an Operating Margin of -3,468.10%.
Operating Margin history for Verastem Oncology from 2019 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -3,468.10% | 4445.73% |
| 2020 | -76.29% | -91.07% |
| 2019 | -854.77% | 215.29% |
| 2018 | -271.11% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 34.61% | -101.72% | 🇺🇸 USA |
 LabCorp LH | 10.63% | -100.53% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 22.54% | -101.12% | 🇬🇧 UK |
 Curis CRIS | -426.66% | -78.75% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.